Berɛboɔ mu kokoram
- Wɔatwerɛ nsɛm wei ɛwɔ Asante kasa mu
has cause | liver cirrhosis, aflatoxins |
---|---|
health specialty | oncology |
symptoms and signs | Yarefufuoɔ, abdominal pain, weight loss, hepatomegaly |
anatomical location | liver |
ICD-9-CM | 155.0, 155.2 |
NCI Thesaurus ID | C34803, C7692 |
Berɛboɔ mu kokoram (brɔfo kasa mu, Liver cancer) yɛ kokoram a efi ase wɔ mberɛboɔ no mu[1]. Berɛboɔ mu kokoram yɛ akwahosan ho haw kɛse wɔ Ghana, na aman a wɔn a wɔnya bi dooso paa wɔ wiase nyinaa no, Ghana yɛ mu biako.[2][3]
Berɛboɔ mu kokoram betumi ayɛ nea edi kan a kokoram no fi ase wɔ mmerɛbo mu, anaasɛ ebetumi ayɛ nea ɛto abien a ɛkɔ mmeae afoforo, a kokoram no trɛw fi nipadua no mmeae afoforo kɔ mmerɛbo no mu.[4][5]
Berɛbo mu kokoram titiriw ne kokoram a ɛto so asia a ɛtaa ba wɔ wiase nyinaa, na ɛno ne kokoram a ɛto so anan a ekunkum nnipa.[6] Wɔ afe 2018 mu no, nnipa 841,000 nyaa bi na ɛmaa nnipa 782,000 wuwui wɔ wiase nyinaa.[6]
Ma ɛde ba
[sesa]Nea ɛde berɛboɔ mu kokoram ba titiriw ne mberɛboɔ mu yare a efi berɛboɔ mu yare B, berɛboɔ mu yare C, anaa nsa.
Berɛboɔ mu yareɛ B ne C
[sesa]Berɛboɔ mu yareɛ B ne C yɛ nneɛma atitiriw a ɛde berɛboɔ mu kokoram ba wɔ wiase nyinaa, na eyi te saa titiriw wɔ Ghana.[7] Ghana wɔ berɛboɔ mu yare B a enni sabea a ɛma obi nya mmerɛbo mu kokoram kɛse. Ɔmanfo akwahosan dawurobɔ a wɔbɔ sɛ wɔbɛbɔ wɔn ho ban afi mmerɛbo mu yare B ho na wɔama mmerɛbo mu yare C nhwehwɛmu ne ayaresa atu mpɔn no hia kɛse wɔ berɛbo mu kokoram dodow a wɔbɛtew so no mu.[8][9]
Wuduro mmoawa (Aflatoxin)
[sesa]Aflatoxin, awuduru bi a fungi bi a wohu wɔ aduan mu na ɛyɛ, yɛ ade titiriw foforo a ɛde mmerɛbo mu kokoram ba wɔ Ghana.[10] Aflatoxin a ɛwɔ nnuan atitiriw te sɛ atoko, nkase, aburo ne asase mu nnuan mu no abu so esiane korabea papa a enyi hɔ enti. Aduan a aflatoxin wom a obi di no betumi ama obi anya mmerɛbo mu kokoram kɛse. Mmɔden a wɔbɔ sɛ wɔbɛma aduan a wɔkora so ne sɛnea wɔde di dwuma no atu mpɔn no ho hia na ama asiane yi abrɛ ase.[11]
Abrabɔ Kwan mu Nneɛma
[sesa]Asetra anaa abrabɔ mu nneyeɛ, a nsanom ne sigaretnom ka ho nso ma mmerɛbo mu kokoram ho asiane ba. Sɛ wode saa nneɛma yi toto berɛboɔ mu yareɛ mmoawa ne aflatoxin a wɔde di dwuma ho no, esua koraa nanso ɛda so ara di dwuma kɛse wɔ mmerɛbo mu kokoram adesoa nyinaa mu wɔ Ghana.[1]
Nsɔano
[sesa]Esiane sɛ nneɛma ahorow pii na ɛde mmerɛbo mu kokoram ba nti, akwan pii wɔ hɔ a wɔfa so siw mmerɛbo mu kokoram ano. Mmɔdenbɔ ahorow yi bi ne nnuru a wɔde ko tia berɛboɔ mu yare B ne n'ayaresa, berɛboɔ mu yare C ayaresa, nsa a wɔnom so tew, aflatoxin a wɔbɛtew so wɔ kuayɛ mu, ne kɛseyɛ mmoroso ne asikyireyare a wɔbɛhwɛ so.[1]
Ɛnyɛ nea wobetumi asa nnipa a wɔanya mmoawa no yare, nanso nnuru a ekum ɔyare mmoawa a wɔde sa yare no betumi atew asiane a ɛwɔ hɔ sɛ wobenya mmerɛbo mu kokoram no so. Ebia aduro chlorophyllin betumi atew aflatoxin nkɛntɛnso so.[12]
Nneɛma a wɔde besiw Berɛboɔ mu kokoram ano ho hia kɛse wɔ Ghana na ama ɔmanfo no anya ahotɔ. Nneɛma a ehia no bi nye;
- Paneɛbɔ nhyehyeɛ: Berɛboɔ mu yareɛ B paneɛbɔ ho nhyehyɛe ahorow a wɔbɛtrɛw mu, titiriw ama mmofra a wɔawo wɔn foforo, na ama wɔatew berɛboɔ mu yareɛ B a enni sabea a ɛba no so.[1]
- Nnipaduamu nhwehwɛmu ne Ayaresa: Berɛboɔ mu yareɛ B ne C nhwehwɛmu ne ayaresa a wɔbɛma anya nkɔso na wɔasiw mmerɛbo mu kokoram a ɛbɛkɔ so no ano titiriw.[13]
- Aduan mu Ahobammɔ: Aduan a wɔkora so yie ne sɛnea wɔde di dwuma yiye bɛboa atew aflatoxin a wɔde gu mu no so.[13]
- Ɔmanfo dawurobɔ: Nneɛma a ɛde berɛboɔ mu kokoram ba no ho nsɛm a wɔbɛma nkurɔfo ate ase ne asetra a ahoɔden wom a wɔbɛhyɛ ho nkuran ye paa.[13][14]
Sua pii
[sesa]- Yafunukeka
- Asikyireyadeɛ
- Ahrawa mu yareɛ
- Berɛboɔ mu yareɛ
- Nsonomuyadeɛ
- Mmogyammorosoɔ
- Yarefufuoɔ
- Sawa mu yareɛ
- Dwoa
Beaɛ a menyaa mmoa fii
[sesa]- ↑ 1.0 1.1 1.2 1.3 Liver cancer - Symptoms and causes (in English), retrieved 2024-06-20
- ↑ Ghana: number of deaths from liver cancer (in English), retrieved 2024-06-20
- ↑ Liver Cancer Foundation, Ghana (in American English), retrieved 2024-06-20
- ↑ Alessandro Mantovani, Giovanni Targher (2017-07-01), "Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease", Annals of Translational Medicine, vol. 5, no. 13, p. 270, doi:10.21037/atm.2017.04.41, ISSN 2305-5839, PMC 5515814, PMID 28758096, retrieved 2024-06-20
- ↑ Jordi Bruix, Kwang-Hyub Han, Gregory Gores, Josep Maria Llovet, Vincenzo Mazzaferro (2015-04-01), "Liver cancer: Approaching a personalized care", Journal of hepatology, vol. 62, no. 1 0, pp. S144–S156, doi:10.1016/j.jhep.2015.02.007, ISSN 0168-8278, PMC 4520430, PMID 25920083, retrieved 2024-06-20
{{citation}}
: CS1 maint: multiple names: authors list (link) - ↑ 6.0 6.1 Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal (2018-11-12), "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA: A Cancer Journal for Clinicians (in English), vol. 68, no. 6, pp. 394–424, doi:10.3322/caac.21492, ISSN 0007-9235, retrieved 2024-06-20
{{citation}}
: CS1 maint: multiple names: authors list (link) - ↑ Hepatitis B (in English), retrieved 2024-06-20
- ↑ Liver Cancer Risk Factors | Risk of Liver Cancer (in English), retrieved 2024-06-20
- ↑ Risk Factors » Hepatitis B Foundation, retrieved 2024-06-20
- ↑ Aflatoxicosis - an overview | ScienceDirect Topics, retrieved 2024-06-20
- ↑ Christian S. Alvarez, Elisa Hernandez, Kira Escobar, Carmen I. Villagran, María F. Kroker-Lobos, Alvaro Rivera-Andrade, Joshua W. Smith, Patricia A. Egner, Mariana Lazo, Neal D. Freedman, Eliseo Guallar, Michael Dean, Barry I. Graubard, John D. Groopman, Manuel Ramírez-Zea, Katherine A. McGlynn (2020-07-01), "Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case–control study", BMJ Open Gastroenterology (in English), vol. 7, no. 1, pp. e000380, doi:10.1136/bmjgast-2020-000380, ISSN 2054-4774, PMID 32641287, retrieved 2024-06-20
{{citation}}
: CS1 maint: multiple names: authors list (link) - ↑ Yujin Hoshida, Bryan C. Fuchs, Kenneth K. Tanabe (2012-11-01), "Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges", Current cancer drug targets, vol. 12, no. 9, pp. 1129–1159, ISSN 1568-0096, PMC 3776581, PMID 22873223, retrieved 2024-06-20
{{citation}}
: CS1 maint: multiple names: authors list (link) - ↑ 13.0 13.1 13.2 What to Expect (in English), retrieved 2024-06-20
- ↑ Liver Health is Public Health - Global Liver Institute (in American English), 2022-04-23, retrieved 2024-06-20